TELOGEN EFFLUVIUM

Clinical trials for TELOGEN EFFLUVIUM explained in plain language.

Never miss a new study

Get alerted when new TELOGEN EFFLUVIUM trials appear

Sign up with your email to follow new studies for TELOGEN EFFLUVIUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 4

Hair loss hope: new drink targets shedding from popular Weight-Loss meds

Symptom relief Recruiting now

This study tests a drinkable nutraceutical supplement called Olistic Next Women to see if it can reduce hair loss in women who are taking GLP-1/GIP receptor agonists (like Ozempic or Mounjaro). About 40 women over age 35 who recently started these drugs will take either the suppl…

Matched conditions: TELOGEN EFFLUVIUM

Phase: NA • Sponsor: Olistic Research Labs S.L. • Aim: Symptom relief

Last updated May 17, 2026 05:33 UTC

TELOGEN EFFLUVIUM

Get alerted when new TELOGEN EFFLUVIUM trials appear

Hair loss hope: new drink targets shedding from popular Weight-Loss meds